Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.
Sponsored By
Prebiotin Tested in NIH/NIDDK Pilot Study with End Stage Renal Disease PatientsPrebiotin Tested in NIH/NIDDK Pilot Study with End Stage Renal Disease Patients
The NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases) Hemodialysis Novel Therapies (HDNT) Study Group has been conducting early phase studies of novel interventions with the long-term goal to test promising therapies in full-scale clinical trials.
October 17, 2017
1 Min Read
.png?width=850&auto=webp&quality=95&format=jpg&disable=upscale "Prebiotin Tested in NIH/NIDDK Pilot Study with End Stage Renal Disease Patients")
The NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases) Hemodialysis Novel Therapies (HDNT) Study Group has been conducting early phase studies of novel interventions with the long-term goal to test promising therapies in full-scale clinical trials.
You May Also Like
